ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 125 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,000 | +40.0% | 14,024 | +75.3% | 0.00% | – |
| Q2 2023 | $30,000 | +57.9% | 7,998 | +38.5% | 0.00% | – |
| Q1 2023 | $19,000 | -63.5% | 5,774 | -45.9% | 0.00% | – |
| Q4 2022 | $52,000 | +100.0% | 10,664 | +135.1% | 0.00% | – |
| Q3 2022 | $26,000 | +73.3% | 4,536 | +123.6% | 0.00% | – |
| Q2 2022 | $15,000 | -63.4% | 2,029 | -63.6% | 0.00% | – |
| Q1 2022 | $41,000 | -59.0% | 5,568 | -50.5% | 0.00% | – |
| Q4 2021 | $100,000 | -65.5% | 11,249 | +36.4% | 0.00% | – |
| Q3 2021 | $290,000 | +118.0% | 8,247 | +33.9% | 0.00% | – |
| Q2 2021 | $133,000 | +121.7% | 6,157 | +530.2% | 0.00% | – |
| Q1 2021 | $60,000 | +300.0% | 977 | +169.9% | 0.00% | – |
| Q4 2020 | $15,000 | – | 362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |